title: Comparison of agar diffusion methodologies for antimicrobial susceptibility testing of Pseudomonas aeruginosa isolates from cystic fibrosis patients.
abstract: Pseudomonas aeruginosa is the most common pathogen infecting the lungs of patients with cystic fibrosis (CF). Improved antimicrobial chemotherapy has significantly increased the life expectancy of these patients. However, accurate susceptibility testing of P. aeruginosa isolates from CF sputum may be difficult because the organisms are often mucoid and slow growing. This study of 597 CF isolates of P. aeruginosa examined the correlation of disk diffusion and Etest (AB BIODISK, Solna, Sweden) results with a reference broth microdilution method. The rates of interpretive errors for 12 commonly used antipseudomonal antimicrobials were determined. The disk diffusion method correlated well (zone diameter versus MIC) for all of the agents tested. However, for mucoid isolates, correlation coefficients (r values) for piperacillin, piperacillin-tazobactam, and meropenem were <0.80. The Etest correlation with reference broth microdilution results (MIC versus MIC) was acceptable for all of the agents tested, for both mucoid and nonmucoid isolates. Category interpretation errors were similar for the disk diffusion and Etest methods with 0.4 and 0.1%, respectively, very major errors (false susceptibility) and 1.1 and 2.2% major errors (false resistance). Overall, both agar diffusion methods appear to be broadly acceptable for routine clinical use in susceptibility testing of CF isolates of P. aeruginosa.
authors.affiliation: Department of Pediatrics, Division of Infectious Disease, University of Washington, Seattle, Washington, USA. jburns@chmc.org
authors.forename: J L
authors.initials: JL
authors.lastname: Burns
authors.forename: L
authors.initials: L
authors.lastname: Saiman
authors.forename: S
authors.initials: S
authors.lastname: Whittier
authors.forename: D
authors.initials: D
authors.lastname: Larone
authors.forename: J
authors.initials: J
authors.lastname: Krzewinski
authors.forename: Z
authors.initials: Z
authors.lastname: Liu
authors.forename: S A
authors.initials: SA
authors.lastname: Marshall
authors.forename: R N
authors.initials: RN
authors.lastname: Jones
mesh_terms: D000362:Agar; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002648:Child; D003550:Cystic Fibrosis / Q000150:complications / Q000382:microbiology*; D006801:Humans; D008168:Lung / Q000382:microbiology*; D008171:Lung Diseases / Q000175:diagnosis / Q000382:microbiology*; D008826:Microbial Sensitivity Tests / Q000379:methods; D011552:Pseudomonas Infections / Q000175:diagnosis / Q000209:etiology*; D011550:Pseudomonas aeruginosa / Q000187:drug effects* / Q000254:growth & development / Q000302:isolation & purification; D015203:Reproducibility of Results; D013183:Sputum / Q000382:microbiology
chemical_list: D000900:Anti-Bacterial Agents; D000362:Agar